Literature DB >> 21678366

Male circumcision for prevention of homosexual acquisition of HIV in men.

Charles Shey Wiysonge1, Eugene J Kongnyuy, Muki Shey, Adamson S Muula, Osric B Navti, Elie A Akl, Ying-Ru Lo.   

Abstract

BACKGROUND: Previous systematic reviews found inconsistent effects of male circumcision on HIV acquisition in men who have sex with men (MSM). However, a number of new studies have become available in the three years since the last systematic review.
OBJECTIVES: To assess the effects of male circumcision for preventing HIV acquisition by men through sex with men. SEARCH STRATEGY: In June 2010 we electronically searched the Cochrane Central Register of Controlled Trials, PubMed, EMBASE, AIDS Education Global Information System, ClinicalTrials.gov, and WHO International Clinical Trials Registry Platform; hand-searched reference lists of relevant articles; and contacted relevant organisations and experts. We updated the search in March 2011. SELECTION CRITERIA: We looked for randomised controlled trials (RCTs) and observational studies that assessed the effects of male circumcision on HIV acquisition in MSM. DATA COLLECTION AND ANALYSIS: Two authors independently assessed study eligibility and methodological quality, and extracted data. We expressed study results as odds ratios (OR) with 95% confidence intervals (CI), and conducted random-effects meta-analysis. MAIN
RESULTS: We found no completed RCT and included 21 observational studies with 71,693 participants. The only eligible RCT is currently ongoing among MSM in China. The pooled effect estimate for HIV acquisition was not statistically significant (20 studies; 65,784 participants; OR 0.86, 95% CI 0.70 to 1.06) and showed significant heterogeneity (I²=53%). In a subgroup analysis, the results were statistically significant in studies of men reporting an insertive role (7 studies, 3465 participants; OR 0.27, 95% CI 0.17 to 0.44; I²=0%) but not in studies of men reporting a receptive role (3 studies, 1792 participants; OR 1.20, 95% CI 0.63 to 2.29; I² = 0%). There was no significant association between male circumcision and syphilis (8 studies; 34,999 participants: OR 0.96, 95% CI 0.82 to 1.13; I² = 0%), herpes simplex virus 1 (2 studies, 2740 participants; OR 0.90, 95% CI 0.53 to 1.52; I²=0%), or herpes simplex virus 2 (5 studies;10,285 participants; OR 0.86, 95% CI 0.62 to 1.21; I²=0%). The overall GRADE quality of evidence was low. None of the included studies assessed adverse effects associated with male circumcision. AUTHORS'
CONCLUSIONS: Current evidence suggests that male circumcision may be protective among MSM who practice primarily insertive anal sex, but the role of male circumcision overall in the prevention of HIV and other sexually transmitted infections among MSM remains to be determined. Therefore, there is not enough evidence to recommend male circumcision for HIV prevention among MSM at present. Further research should be of high quality and further explore interaction with the predominant sexual role.

Entities:  

Mesh:

Year:  2011        PMID: 21678366     DOI: 10.1002/14651858.CD007496.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  42 in total

1.  Towards a gender perspective in qualitative research on voluntary medical male circumcision in east and southern Africa.

Authors:  Guillermo Martínez Pérez; Laura Triviño Durán; Angel Gasch; Nicole Desmond
Journal:  Glob Public Health       Date:  2015-03-02

2.  Predicting the long-term impact of voluntary medical male circumcision on HIV incidence among men who have sex with men in Beijing, China.

Authors:  Chen Zhang; Glenn F Webb; Jie Lou; Brian E Shepherd; Han-Zhu Qian; Yu Liu; Sten H Vermund
Journal:  AIDS Care       Date:  2019-10-16

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

4.  Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.

Authors:  Samuel M Jenness; Kevin M Weiss; Steven M Goodreau; Thomas Gift; Harrell Chesson; Karen W Hoover; Dawn K Smith; Albert Y Liu; Patrick S Sullivan; Eli S Rosenberg
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

5.  Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.

Authors:  Samuel M Jenness; Steven M Goodreau; Eli Rosenberg; Emily N Beylerian; Karen W Hoover; Dawn K Smith; Patrick Sullivan
Journal:  J Infect Dis       Date:  2016-07-14       Impact factor: 5.226

Review 6.  Advances in HIV prevention for serodiscordant couples.

Authors:  Kathryn E Muessig; Myron S Cohen
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

7.  Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model.

Authors:  Kevin M Maloney; Adrien Le Guillou; Robert A Driggers; Supriya Sarkar; Emeli J Anderson; Amyn A Malik; Samuel M Jenness
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

8.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (abridged version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

9.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

Review 10.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.